{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:33Z","timestamp":1786119153835,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/cco.0b013e3283094ec7","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:53:39Z","timestamp":1236272019000},"page":"522-528","source":"Crossref","is-referenced-by-count":23,"title":["Management of AIDS-related lymphoma"],"prefix":"10.1097","volume":"20","author":[{"given":"Alexandra M","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection: National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jama.1991.03470010088036","article-title":"Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS related lymphoma: a prospective multiinstitutional trial","volume":"266","author":"Levine","year":"1991","journal-title":"JAMA"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200307040-00013","article-title":"Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma","volume":"17","author":"Hoffmann","year":"2003","journal-title":"AIDS"},{"key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","article-title":"Prognostic factors in HIV related diffuse large cell lymphoma: before versus after highly active antiretroviral therapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"R7-7-20210128","first-page":"987","article-title":"The International non-Hodgkins Lymphoma Prognostic Factors Project.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-143-4-200508160-00007","article-title":"A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy","volume":"143","author":"Bower","year":"2005","journal-title":"Ann Intern Med"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","article-title":"Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1200\/JCO.2004.10.093","article-title":"Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response","volume":"22","author":"Levine","year":"2004","journal-title":"J Clin Oncol"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-107-4-502","article-title":"Azidothymidine (AZT) and bone marrow failure in AIDS","volume":"107","author":"Gill","year":"1987","journal-title":"Ann Intern Med"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase III trial of CHOP with or without rituximab in patients with HIV associated non-Hodgkin's lymphoma: AIDS Malignancy Consortium trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"R17-7-20210128","first-page":"29a","article-title":"Introduction of combined CHOP-rituximab therapy dramatically improved outcome of diffuse large B cell lymphoma in British Columbia [Abstract 88]","volume":"102","author":"Sehn","year":"2003","journal-title":"Blood"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1200\/JCO.2005.05.4684","article-title":"Phase II trial of CHOP plus rituximab in patients with HIV associated non-Hodgkin's lymphoma","volume":"24","author":"Bou\u00e9","year":"2006","journal-title":"J Clin Oncol"},{"key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials","volume":"105","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/10428190701411441","article-title":"Rituximab-related viral infections in lymphoma patients","volume":"48","author":"Aksoy","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.6004\/jnccn.2008.0017","article-title":"Infectious complications associated with immunomodulating monoclonal antibodies used in the treatment of hematologic malignancy","volume":"6","author":"Koo","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2002-11-3442","article-title":"Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B cell lymphoma","volume":"101","author":"Mournier","year":"2003","journal-title":"Blood"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-11-3911","article-title":"Rituximab and ICE as second line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B cell lymphoma","volume":"103","author":"Kewalramani","year":"2004","journal-title":"Blood"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00042560-200112150-00002","article-title":"High dose cytosine arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS related non-Hodgkin's lymphoma","volume":"28","author":"Bi","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","article-title":"Durable remissions with autologous stem cell transplantation for high risk HIV associated lymphomas","volume":"105","author":"Krishnan","year":"2004","journal-title":"Blood"},{"key":"R26-7-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","article-title":"Dose reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus associated lymphoma: AIDS Malignancy Consortium Study 020","volume":"14","author":"Spitzer","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1200\/JCO.2005.11.973","article-title":"AIDS related Burkitt's lymphoma versus diffuse large cell lymphoma in the prehighly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"R28-7-20210128","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1200\/JCO.2005.02.9561","article-title":"Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era","volume":"23","author":"Spina","year":"2005","journal-title":"J Clin Oncol"},{"key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high dose methotrexate\/ifosfamide, etoposide, and high dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"R30-7-20210128","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"R31-7-20210128","first-page":"445","article-title":"Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B cell lymphoma or leukaemia. Results of the PETHEMA-LAL3\/97 study","volume":"88","author":"Oriol","year":"2003","journal-title":"Haematologica"},{"key":"R32-7-20210128","first-page":"990","article-title":"Highly active antiretroviral therapy and outcome of AIDS related Burkitt's lymphoma or leukaemia. Results of the PETHAMA-LAL 3\/97 study","volume":"90","author":"Oriol","year":"2005","journal-title":"Haematologica"},{"key":"R34-7-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/apc.2007.0124","article-title":"Improving outcomes for patients with Burkitt lymphoma and HIV","volume":"22","author":"Blinder","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R35-7-20210128","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"R36-7-20210128","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIVAIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"R37-7-20210128","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0002-9440(10)65424-7","article-title":"High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T cell infiltrate in Hodgkin's lymphoma","volume":"154","author":"Van den Berg","year":"1999","journal-title":"Am J Pathol"},{"key":"R38-7-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ijc.10218","article-title":"Infiltration of tTh1 and Th2 lymphocytes around Hodgkin and Reed Sternberg cells in Hodgkin disease: relation with expression of CXC and CC chemokines on H and $S cells","volume":"98","author":"Ohshima","year":"2002","journal-title":"Int J Cancer"},{"key":"R39-7-20210128","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"R40-7-20210128","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1182\/blood-2006-09-047498","article-title":"Hodgkin lymphoma: to the HAART of the matter","volume":"108","author":"Levine","year":"2006","journal-title":"Blood"},{"key":"R41-7-20210128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.jncimonographs.a024171","article-title":"Hodgkin's disease in the setting of human immunodeficiency virus infection","volume":"23","author":"Levine","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R42-7-20210128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/QAI.0b013e31815e722b","article-title":"Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy","volume":"47","author":"Berenguer","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R43-7-20210128","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/00000478-199612000-00012","article-title":"Pathological, immunological and molecular features of Hodgkin's disease associated with HIV infection: comparison with ordinary Hodgkin's disease","volume":"20","author":"Bellas","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R44-7-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2004.04934.x","article-title":"Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus associated Hodgkin's disease","volume":"125","author":"Hoffmann","year":"2004","journal-title":"Br J Haematol"},{"key":"R45-7-20210128","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/00002030-200209270-00020","article-title":"Prognostic impact of highly active antiretroviral therapy in HIV related Hodgkin's disease","volume":"16","author":"Ribera","year":"2002","journal-title":"AIDS"},{"key":"R46-7-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00042560-200008150-00009","article-title":"Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte colony stimulating factor in HIV infected patients with newly diagnosed Hodgkin's disease: a prospective multi-institutional AIDS clinical trials group study (ACTG 149)","volume":"24","author":"Levine","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R47-7-20210128","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"key":"R48-7-20210128","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdg408","article-title":"BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection","volume":"14","author":"Hartmann","year":"2003","journal-title":"Ann Oncol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCO.0b013e3283094ec7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:40:32Z","timestamp":1786038032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-200809000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e3283094ec7","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}